91 related articles for article (PubMed ID: 7908456)
1. Kinetics and specificities of the T helper-cell response to gp120 in the asymptomatic stage of HIV-1 infection.
Geretti AM; Van Baalen CA; Borleffs JC; Van Els CA; Osterhaus AD
Scand J Immunol; 1994 Apr; 39(4):355-62. PubMed ID: 7908456
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive T-cell epitope mapping of HIV-1 env antigens reveals many areas recognized by HIV-1-seropositive and by low-risk HIV-1-seronegative individuals.
Mutch D; Underwood J; Geysen M; Rodda S
J Acquir Immune Defic Syndr (1988); 1994 Sep; 7(9):879-90. PubMed ID: 7519672
[TBL] [Abstract][Full Text] [Related]
3. The naive repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV.
Manca F; Habeshaw J; Dalgleish A
J Immunol; 1991 Mar; 146(6):1964-71. PubMed ID: 1706385
[TBL] [Abstract][Full Text] [Related]
4. CD4 responses to conserved HIV-1 T helper epitopes show both negative and positive associations with virus load in chronically infected subjects.
Boaz MJ; Waters A; Murad S; Easterbrook PJ; D'Sousa E; van Wheeley C; Vyakarnam A
Clin Exp Immunol; 2003 Dec; 134(3):454-63. PubMed ID: 14632751
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals.
Clerici M; Stocks NI; Zajac RA; Boswell RN; Bernstein DC; Mann DL; Shearer GM; Berzofsky JA
Nature; 1989 Jun; 339(6223):383-5. PubMed ID: 2524668
[TBL] [Abstract][Full Text] [Related]
6. Preservation of Peripheral T Follicular Helper Cell Function in HIV Controllers.
Buranapraditkun S; Pissani F; Teigler JE; Schultz BT; Alter G; Marovich M; Robb ML; Eller MA; Martin J; Deeks S; Michael NL; Streeck H
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468877
[TBL] [Abstract][Full Text] [Related]
7. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
[TBL] [Abstract][Full Text] [Related]
8. Helper T-cell recognition of HIV-1 Tat synthetic peptides.
Blazevic V; Ranki A; Mattinen S; Valle SL; Koskimies S; Jung G; Krohn KJ
J Acquir Immune Defic Syndr (1988); 1993 Aug; 6(8):881-90. PubMed ID: 7686223
[TBL] [Abstract][Full Text] [Related]
9. T cell recognition of HIV synthetic peptides in a natural infection.
Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
[TBL] [Abstract][Full Text] [Related]
10. Immunological characteristics of the putative CD4-binding site of the HIV-1 envelope protein.
Kieber-Emmons T; Krowka JF; Boyer J; Ugen KE; Williams WV; Morrow WJ; Weiner DB
Pathobiology; 1992; 60(4):187-94. PubMed ID: 1388715
[TBL] [Abstract][Full Text] [Related]
11. Primary in vitro sensitization of human T-helper lymphocytes by peptides derived from the V3 loop of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein.
Billaud JN; Yagello M; Gluckman JC
Vaccine; 1994 Jan; 12(1):46-55. PubMed ID: 8303940
[TBL] [Abstract][Full Text] [Related]
12. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro.
Clerici M; Lucey DR; Berzofsky JA; Pinto LA; Wynn TA; Blatt SP; Dolan MJ; Hendrix CW; Wolf SF; Shearer GM
Science; 1993 Dec; 262(5140):1721-4. PubMed ID: 7903123
[TBL] [Abstract][Full Text] [Related]
13. Natural analogue peptides of an HIV-1 GP120 T-helper epitope antagonize response of GP120-specific human CD4 T-cell clones.
Fenoglio D; Li Pira G; Lozzi L; Bracci L; Saverino D; Terranova P; Bottone L; Lantero S; Megiovanni A; Merlo A; Manca F
J Acquir Immune Defic Syndr; 2000 Jan; 23(1):1-7. PubMed ID: 10708050
[TBL] [Abstract][Full Text] [Related]
14. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
Cohen S; Tuen M; Hioe CE
AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
[TBL] [Abstract][Full Text] [Related]
15. Immunization with subunit human immunodeficiency virus vaccine generates stronger T helper cell immunity than natural infection.
Clerici M; Tacket CO; Via CS; Lucey DR; Muluk SC; Zajac RA; Boswell RN; Berzofsky JA; Shearer GM
Eur J Immunol; 1991 Jun; 21(6):1345-9. PubMed ID: 1845391
[TBL] [Abstract][Full Text] [Related]
16. Human immunodeficiency virus type 1 evades T-helper responses by exploiting antibodies that suppress antigen processing.
Chien PC; Cohen S; Tuen M; Arthos J; Chen PD; Patel S; Hioe CE
J Virol; 2004 Jul; 78(14):7645-52. PubMed ID: 15220439
[TBL] [Abstract][Full Text] [Related]
17. Helper and cytotoxic T cell responses of HIV type 1-infected individuals to synthetic peptides of HIV type 1 Rev.
Blazevic V; Ranki A; Krohn KJ
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1335-42. PubMed ID: 8573390
[TBL] [Abstract][Full Text] [Related]
18. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
Clerici M; Stocks NI; Zajac RA; Boswell RN; Lucey DR; Via CS; Shearer GM
J Clin Invest; 1989 Dec; 84(6):1892-9. PubMed ID: 2574188
[TBL] [Abstract][Full Text] [Related]
19. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI).
Bell SJ; Cooper DA; Kemp BE; Doherty RR; Penny R
Clin Exp Immunol; 1992 Oct; 90(1):6-12. PubMed ID: 1395102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
